Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAICS | P22234 | 13/20 | 0.49 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.37 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.37 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2C18 | P33260 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | WDR5 | P61964 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24220472 | 0.92 | PAICS (0.58) | PAICS | |
| SCHEMBL24220491 | 0.86 | PAICS (0.42) | PAICSKCNH2 | |
| SCHEMBL20352153 | 0.85 | PAICS (0.43) | PAICSKCNH2 | |
| SCHEMBL21571665 | 0.85 | PAICS (0.49) | PAICSKCNH2IRAK4HDAC3HDAC2 | |
| SCHEMBL24220536 | 0.84 | PAICS (0.43) | PAICS | |
| SCHEMBL24220529 | 0.83 | PAICS (0.49) | PAICSKCNH2IRAK4HDAC3HDAC2 | |
| SCHEMBL20352103 | 0.79 | PAICS (0.53) | PAICS | |
| SCHEMBL20340330 | 0.79 | PAICS (0.45) | PAICSKCNH2IRAK4HDAC3HDAC2 | |
| SCHEMBL20350506 | 0.79 | PAICS (0.44) | PAICSIRAK4 | |
| SCHEMBL20352094 | 0.79 | PAICS (0.37) | PAICSKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3562824-B1 | OXAZOLE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER | LIFEARC (GB) | 2022-01-26 | — | — | EP | disclosed |
| WO-2018122549-A1 | OXAZOLE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER | LIFEARC (GB) | 2018-07-05 | — | — | WO | disclosed |